ebook Munafa Stock Market Course + Intraday & FNO calls  

       

524816 announcements Natco Pharm announcements and dividends declared BSE

Natco Pharm Complete list of announcements declared & dividend announcements by Natco Pharm 524816

Natco Pharm 524816 listed on BSE and deals in

Announcements and dividends declared by Natco Pharm 524816

Natco Pharma forays into pheromone-based technology for integrated pest management
"During Kharif 2021, NATCO plans to launch its first green label pheromone product for effective management of Pink Bollworm (PBW) in cotton crop, under its brand NATMATE PBW," it added.
Announcement as on 15 March 2021

Natco Pharma launches epilepsy treatment drug Brivaracetam in India
The company has launched Brivaracetam tablets under brand BRECITA in India, Natco Pharma said in a regulatory filing.
Announcement as on 26 February 2021

Natco Pharma Q3 results: Net profit declines 39% to Rs 63 crore
The consolidated total income of the company stood at Rs 386 crore for the quarter under consideration. It was Rs 513 crore for the same period a year ago, it added.
Announcement as on 11 February 2021

Natco Pharma gets registration approval from CIB&RC for Chlorantraniliprole
"Natco Pharma is pleased to announce its registration approval given by Central Insecticide Board & Registration Committee (CIB&RC)... for indigenous manufacture of Chlorantraniliprole {CTPR) Technical," the company said in a regulatory filing.
Announcement as on 05 February 2021

Natco Pharma launches anti blood clot medication, Rivaroxaban, in India
Rivaroxaban is an anticoagulant medication used to treat and prevent blood clots. The medication is currently sold by Bayer under the brand name of Xarelto, in the Indian market.
Announcement as on 17 December 2020

Announcements by Natco Pharm first page | Next page | Prev page |

524816 Natco Pharm current price & indicator signals

Moving Averages for Natco Pharm

  • 5Day Average: 874.72
  • 12Day Average: 893.73
  • 20Day Average: 904
  • 50Day Average: 919.84
  • 100Day Average: 994.05
  • 150Day Average: 964.23
  • 200Day Average: 943.75

524816 Indicators & signals

Indicator MACD (12,26,9)

888.9, 905.99, -13.33
Indicator MACD is in negative zone

Indicator ADX (14)

8.21, 17.09, 20.15
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 46
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of 524816 Natco Pharm are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
26 Wed Aug 2026 863.45 858.40 to 880.60 -0.35% 0.65 times
25 Tue Aug 2026 866.45 865.25 to 889.95 -1.92% 0.5 times
24 Mon Aug 2026 883.45 876.90 to 892.40 0.11% 0.82 times
21 Fri Aug 2026 882.50 877.95 to 900.00 0.54% 0.7 times
20 Thu Aug 2026 877.75 875.30 to 894.30 -1.05% 0.65 times
19 Wed Aug 2026 887.05 883.10 to 916.60 -1.2% 0.28 times
18 Tue Aug 2026 897.80 889.70 to 900.10 0.91% 0.35 times
17 Mon Aug 2026 889.70 870.70 to 898.85 -1.41% 1.15 times
14 Fri Aug 2026 902.40 885.75 to 962.25 -5.23% 3.53 times
13 Thu Aug 2026 952.25 917.60 to 960.40 4.07% 1.56 times
12 Wed Aug 2026 915.00 906.00 to 922.00 0.89% 0.46 times
11 Tue Aug 2026 906.90 903.55 to 929.40 -0.5% 0.73 times

Videos related to: 524816 announcements Natco Pharm announcements and dividends declared BSE

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

524816 announcements Natco Pharm announcements and dividends declared BSE

 

Back to top